Skip to main content

CAPLIPOINT · Caplin Point Laboratories Limited · Financials

2,386.50 INR -1.90 (-0.08%) At close · Nov 13
Volume · Nov 13 11.4K Avg daily vol (3M) 12.87K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
21.87B +12.9%
FY2026 Revenue FY2018–FY2026
Net Income
6.41B +13.8%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
5.23B +21%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2018
INR 23.83B 21.87B 19.37B 16.94B 14.67B 12.69B 10.61B 8.63B 5.4B
INR 831.9M 727.7M 659.6M 534.4M 449.9M 469M 369.7M 316.19M 189.95M
INR 9.4M 8.7M 6.1M 7.8M 7.8M 7M 15.9M 3.2M 612K
INR — 8.03B — 5.64B 4.51B 3.86B 3.14B 2.69B 1.88B
INR 1.75B 1.53B 1.36B 1.03B 743.6M 773.7M 621.8M 543.79M 437.43M
INR 6.89B 6.41B 5.63B 4.57B 3.76B 3.08B 2.42B 2.15B 1.45B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 1.71B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.